Companion Dx activity shines new light on IVD sector - is it all good?
This article was originally published in Clinica
Executive Summary
Developments on the regulatory and business front in the area of companion diagnostics made 2011 a pivotal year for both personalised medicine as a concept and for IVD manufacturers as a group. But might stricter regulation hinder testing in general? asks IBI analyst Ashley Yeo